North Carolina Healthcare Association thanks Sen. Thom Tillis for Signing on to 340B Letter  

Cary, NC – Sept. 17, 2020Hospitals and health systems in North Carolina are devoted to improving the health of their patients and communities, including by supporting the 340B drug savings program which allows eligible hospitals serving vulnerable communities to stretch scarce federal resources as far as possible. The North Carolina Healthcare Association (NCHA) thanks U.S. Senator Thom Tillis for standing up for our patients by signing on to a ‘Dear Colleague’ Letter on the 340B contract pharmacy issue today in response to recent actions taken by a number of drug companies to undermine the program designed to deliver medications to our most vulnerable patients. The letter urges the Department of Health and Human Services (HHS) to use its authority to stop this conduct and require these companies to comply with the law.  


Because the 340B program is not funded by federal dollars, it does not cost the government anything, but it makes a big difference to vulnerable North Carolina communities. We thank Senator Tillis for standing with North Carolina’s health systems and hospitals on this issue.    

About NCHA

Founded in 1918, North Carolina Healthcare Association (NCHA) is the united voice of the North Carolina healthcare community. Representing more than 130 hospitals, health systems, physician groups and other healthcare organizations, NCHA works with our members to improve the health of North Carolina communities by advocating for sound public policies and collaborative partnerships and by providing insights, services, support and education to expand access to high quality, efficient, affordable and integrated health care for all North Carolinians. 


Media contact:

Cynthia Charles, NCHA
Phone: (919) 677-4223 (office); (336) 816-4939 (mobile) 


Visit Us







North Carolina Healthcare Association

5440 Wade Park Blvd, Suite 410
Raleigh, NC 27607

Main: 919-677-2400
Fax: 919-677-4200
Mail to: PO Box 4449, Cary, NC 27519-4449

Contact Us

Follow Us